Therapeutics & Vaccines
Compositions And Methods For Treating Hyperphosphatemia In Humans
WARF: P07020US
Inventors: Mark Cook, Keith Crawford, Erica Hellestad, Christian Helvig, Martin Petkovich
The Invention
A method for reducing phosphate absorption in a human or non-human animal subject at risk of developing or having developed hyperphosphatemia is disclosed. The method includes the step of administering orally to the subject an anti-intestinal sodium phosphate cotransporter type 2B (Npt2B) antibody in an amount effective to reduce or maintain the serum phosphate concentration in the subject.
Tech Fields
For current licensing status, please contact Emily Bauer at [javascript protected email address] or 608-960-9842